Search

Your search keyword '"Bitton, Alain"' showing total 904 results

Search Constraints

Start Over You searched for: Author "Bitton, Alain" Remove constraint Author: "Bitton, Alain"
904 results on '"Bitton, Alain"'

Search Results

1. Environmental Factors Associated With Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project

2. After Surgically Induced Remission, Ileal and Colonic Mucosa-Associated Microbiota Predicts Crohn’s Disease Recurrence

4. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

5. Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

6. Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis

7. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

10. Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis.

11. Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study

12. Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study

13. Variation in the Care of Children with Inflammatory Bowel Disease Within and Across Canadian Provinces: A Multi-Province Population-Based Cohort Study

14. Hospitalization with Clostridioides difficile in pediatric inflammatory bowel disease: a population-based study

16. Anti-microbial antibody response is associated with future onset of Crohn’s disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk

20. Clinical Predictors of Early and Late Endoscopic Recurrence Following Ileocolonic Resection in Crohn’s Disease

22. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease

24. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data

26. Clinical Predictors of Early and Late Endoscopic Recurrence Following Ileocolonic Resection in Crohn's Disease.

27. The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape

28. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD

29. The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease

30. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD

31. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors

32. The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care

33. The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD

34. The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs

35. Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

36. The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD

37. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs

38. The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease

39. Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Toward Sustaining Healthcare Delivery

40. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

45. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

47. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary

Catalog

Books, media, physical & digital resources